Chimeric foot-and-mouth disease viruses: evaluation of their efficacy as potential marker vaccines in cattle (Q40113607)

17 September 2017

title

Chimeric foot-and-mouth disease viruses: evaluation of their efficacy as potential marker vaccines in cattle (English)

1 reference

17 September 2017

main subject

foot-and-mouth disease

1 reference

V L Fowler

1 reference

17 September 2017

D J Paton

series ordinal

1 reference

17 September 2017

E Rieder

series ordinal

1 reference

17 September 2017

P V Barnett

series ordinal

1 reference

17 September 2017

language of work or name

English

0 references

publication date

22 February 2008

1 reference

17 September 2017

1 reference

inferred from page(s)

published in

Vaccine

1 reference

17 September 2017

1 reference

17 September 2017

1 reference

17 September 2017

page(s)

1982-1989

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.012

17 September 2017

1 reference

Emergency vaccination against foot-and-mouth disease: rate of development of immunity and its implications for the carrier state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.012

Evidence for an internal antigen in foot-and-mouth disease virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.012

A survey of Toxocara infections in cat breeding colonies in The Netherlands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.012

Differentiation of infection from vaccination in foot-and-mouth disease by the detection of antibodies to the non-structural proteins 3D, 3AB and 3ABC in ELISA using antigens expressed in baculovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.012

7 January 2021

Novel vaccine strategies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.012

The use of marker vaccines in eradication of herpesviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.012

Experimental non-transmissible marker vaccines for classical swine fever (CSF) by trans-complementation of E(rns) or E2 of CSFV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.012

Classical swine fever virus E(rns) deletion mutants: trans-complementation and potential use as nontransmissible, modified, live-attenuated marker vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.012

Newcastle disease virus (NDV) marker vaccine: an immunodominant epitope on the nucleoprotein gene of NDV can be deleted or replaced by a foreign epitope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.012

Generation of a recombinant chimeric Newcastle disease virus vaccine that allows serological differentiation between vaccinated and infected animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.012

Generation of a candidate live marker vaccine for equine arteritis virus by deletion of the major virus neutralization domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.012

Foot-and-mouth disease virus receptors: comparison of bovine alpha(V) integrin utilization by type A and O viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.012

Specificity of the VP1 GH loop of Foot-and-Mouth Disease virus for alphav integrins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.012

Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.012

Antibodies against a preselected peptide recognize and neutralize foot and mouth disease virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.012

Routine application of enzyme-linked immunosorbent assay in comparison with complement fixation for the diagnosis of foot-and-mouth and swine vesicular diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.012

Implementation of a one-step real-time RT-PCR protocol for diagnosis of foot-and-mouth disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.012

Detection of all seven serotypes of foot-and-mouth disease virus by real-time, fluorogenic reverse transcription polymerase chain reaction assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.012

Antigenic variation in foot-and-mouth disease: studies based on the virus neutralization reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.012

Comparative evaluation of six ELISAs for the detection of antibodies to the non-structural proteins of foot-and-mouth disease virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.012

Foot-and-mouth disease non-structural protein serology in cattle: use of a Bayesian framework to estimate diagnostic sensitivity and specificity of six ELISA tests and true prevalence in the field.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.012

Evidence that high potency foot-and-mouth disease vaccine inhibits local virus replication and prevents the "carrier" state in sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.012

Further studies on the early protective responses of pigs following immunisation with high potency foot and mouth disease vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.012

Protection against direct-contact challenge following emergency FMD vaccination of cattle and the effect on virus excretion from the oropharynx.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.012

Longevity of antibody and cytokine responses following vaccination with high potency emergency FMD vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.012

Emergency vaccination of sheep against foot-and-mouth disease: protection against disease and reduction in contact transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.012

Analysis of neutralizing antigenic sites on the surface of type A12 foot-and-mouth disease virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.012

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2008.02.012

1 reference

17 September 2017

1 reference